Kárteszi M, Szalay L, Cornides A, Dávid K, Fehér J
2nd Department of Internal Medicine, Semmelweis University Medical School, Budapest.
Acta Med Hung. 1988;45(3-4):277-86.
Serum concentration of the aminoterminal peptide of procollagen type III (P III P) and that of the high-molecular-weight glycoprotein laminin P1 (LP1) were determined by a specific radioimmunoassay (RIA) in patients with different chronic liver diseases. Besides the routine laboratory tests, histological verification of the liver samples obtained by needle biopsy and a complex hepatitis B virus marker analysis by RIA (Biomedica-Sorin), or ELISA (Behringwerke, Marburg, FRG) kits were carried out in order to set up the correct clinical diagnosis. In normal controls, the P III P and LP1 concentrations were 7.8 +/- 1.1 ng/ml (n = 10) and 0.08 +/- 0.1 units/ml (n = 7), respectively. Patients with fatty liver (n = 25) showed a significant elevation in P III P concentration (18.6 +/- 2.7 ng/ml). Such an elevation was not unequivocally demonstrated before. In this group of patients LP1 level was also increased (1.4 +/- 0.2 units/ml, n = 10). In liver cirrhosis (n = 51) both P III P and LP1 concentrations were found to be consistently elevated.
采用特异性放射免疫分析法(RIA)测定了不同慢性肝病患者血清中Ⅲ型前胶原氨基端肽(PⅢP)和高分子量糖蛋白层粘连蛋白P1(LP1)的浓度。除常规实验室检查外,还对经针吸活检获取的肝组织样本进行了组织学验证,并采用RIA(Biomedica-Sorin)或ELISA(德国马尔堡贝林werke公司)试剂盒进行了复杂的乙肝病毒标志物分析,以确立正确的临床诊断。正常对照组中,PⅢP和LP1浓度分别为7.8±1.1 ng/ml(n = 10)和0.08±0.1单位/ml(n = 7)。脂肪肝患者(n = 25)的PⅢP浓度显著升高(18.6±2.7 ng/ml)。此前尚未明确证实有如此升高的情况。在该组患者中,LP1水平也升高(1.4±0.2单位/ml,n = 10)。在肝硬化患者(n = 51)中,发现PⅢP和LP1浓度均持续升高。